No Data
No Data
Chalkis Health Industry Co., Ltd's (SZSE:000972) 25% Price Boost Is Out Of Tune With Earnings
Chalkis Health Industry: Summary of Half-Year Report in 2024.
Chalkis Health Industry: Half-year report for the year 2024.
Chalkis Health Industry (000972.SZ): Terminates the implementation of the 2023 restricted stock incentive plan.
On August 21st, Geelong reported that chalkis health industry (000972.SZ) has announced the purpose of launching the 2023 restricted stock incentive plan is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, effectively combine the interests of shareholders, company, and core team individuals, so that all parties pay attention to the company's long-term development together, and bring sustained returns to shareholders. Advocate the concept of continuous development between the company and individuals, build a community of interests among shareholders, companies, and employees, mobilize the enthusiasm of core talents, and promote the company's long-term stable development; establish a compensation, equity, and
Chalkis Health Industry (000972.SZ): The net income in the first half of the year was 11.8014 million yuan, a year-on-year decrease of 69.01%.
On August 21st, Chalkis Health Industry (000972.SZ) released its 2024 interim report, with a reported revenue of 0.245 billion yuan, a decrease of 14.86% year-on-year; a net income attributable to the shareholders of the listed company of 11.8014 million yuan, a decrease of 69.01% year-on-year; a net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses of 3.1979 million yuan, down 91.49% year-on-year; and an EPS of 0.0153 yuan.
Chalkis Health Industry Co., Ltd (SZSE:000972) Stock Catapults 27% Though Its Price And Business Still Lag The Market
No Data
No Data